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Abstract
Background:
 
Menopause is a natural phase of life, but it can bring about
physical problems for women. It seems that hormone replacement therapy
(HRT)  can  be  helpful  in  preventing  problems  at  this  stage  of  life.  Patient
and physician attitudes regarding menopause and HRT may affect decisions
about the use of HRT. This study was conducted to determine attitudes
about the importance of sex in menopausal women and examine the rela-
tionship between HRT and sex life after menopause.
 
Methods:
 
This is a comparative study that was done in the year 2000. The
questionnaire used had two main parts. One hundred and fifty-four women
receiving HRT were chosen from private gynecology clinics north of Tehran
city and 130 women who were not receiving HRT were chosen from the
neighborhood  of  the  HRT  group.  The  sex  lives  and  attitudes  towards
sex  of the women before and after menopause were then compared, and
the results were tabulated in 55 tables. Descriptive and inferential statistical
methods were used.
 
Results:
 
The average age in the HRT group was 53 years and that in the
non-HRT group was 56 years. There was a significant difference in the
average age between the two groups (
 
P
 
 
 
<
 
 0.001). The average number of
years post-menopause was 3.9 in the HRT group and 5.9 in the non-HRT
group. In the HRT group, 91.9% of the women used the hormone as pre-
scribed by their physician. In this group, 85.7% of the women were of the
opinion that sex was important, but this proportion in the non-HRT group
was 25.4%. There was a significant difference between the HRT and non-
HRT groups (
 
P
 
 
 
<
 
 0.001). Compared to the attitudes before menopause, the
attitudes about the importance of sex in 56.5% of the HRT group and 19.2%
of the non-HRT group did not change after menopause. Women receiving
HRT fared better in all aspects of their sex life, including libido, sexual
activity, sexual satisfaction, sexual pleasure, frequency of orgasms and sex-
ual importance at the time of the study. There were significant differences
between the HRT and non-HRT groups (
 
P
 
 
 
<
 
 0.001). With respect to sexual
pleasure, 6.5% of the HRT group and 4.6% of the non-HRT group experi-
enced greater pleasure; 68.5% of the HRT group and 11.5% of the non-HRT
group experienced no change; and 83.8% of the non-HRT group experi-
enced less pleasure. There was a significant difference between the two
groups with respect to the change in sexual pleasure (
 
P
 
 
 
<
 
 0.001).
 
Conclusion:
 
Although the importance of sex decreased for elderly women
in both the HRT group and non-HRT group, HRT affected their attitudes
about the importance of sex. There was a significant difference between the
HRT group and non-HRT group in this area (
 
P
 
 
 
<
 
 0.001). The importance of
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INTRODUCTION
 
Menopause is a natural phase of life, but it can bring
about physical problems for women. The menopausal
syndrome includes a variety of symptoms, such as
fatigue, headache, nervousness, loss of libido, insom-
nia, depression, irritability, palpitations, and joint and
muscle pain.
 
1
 
 It is also often accompanied by physical
symptoms like hot flushes and emotional changes,
such as mood swings. There is an increased tendency
towards obesity.
 
2
 
 Stadberg 
 
et al
 
. found the prevalence
of climacteric symptoms as follows: vasomotor symp-
toms (53%), depression/irritability (57%), disturbed
sleep (52%), muscle/joint pain (57%), loss of libido
(37%) and vaginal dryness (27%).
 
3
 
 Vaginal discomfort
is often accompanied by a loss of libido and disrup-
tion of interpersonal relations.
 
4
 
 The sex drive may not
be diminished, but some women find it difficult to
accept that they are no longer fertile.
 
2
 
These changes are caused by a fall in the pro-
duction of estrogen by the ovaries.
 
2
 
 The exhaustion
of gonadothropine-responsive follicular unites is
responsible for the reduction in estrogen secretion
and the cessation of menses.
 
5
 
 Haas and Schiff have
reported that the effect of menopause on women’s
health varies. Estimates indicate that 75% of meno-
pausal women experience some problems or discom-
fort, but only 10–20% seek medical help.
 
6
 
 According
to Blumberg 
 
et al.
 
, physicians tend to define meno-
pause as a deficiency disease; that is, characterized
by a lack of estrogen that is correctable by hormone
replacement therapy (HRT).
 
7
 
 It seems that HRT can
be helpful in preventing problems at this stage of life.
Since the 1980s, many doctors have begun to recom-
mend HRT because of its potential for preventing
osteoporosis, cardiovascular disease and Alzheimer’s
disease.
 
8,9
 
 According to Beck, hormone replacement
usually eliminates hot flushes and night sweats. Estro-
gen replacement provides a good prophylaxis against
atrophic vaginitis, dysparunia and degenerative
changes in the urethra and urinary bladder. Affective
symptoms—depression, insomnia, irritability and loss
of concentration—generally are improved with estro-
gen therapy. Atrophic vaginitis requires continuous
therapy, but vaginal relaxation is not responsive to
estrogen therapy. Hormone replacement also induces
a series of changes, which help the skin to retain a
youthful appearance.
 
1
 
 According to Kingsberg, HRT
in menopausal women improves the sexual function
and protects their genital health.
 
10
 
The prevalence of current HRT use in the study
conducted by Ghali 
 
et al.
 
 was 19.8%, whereas 31.2%
were either current or former HRT users. They have
suggested that proper communication might enhance
HRT counseling and assist women in making deci-
sions.
 
11
 
 The estimated percentages of HRT users in
different countries are as follows: 2% in Italy, 4% in
Spain, 15% in the Netherlands, 20% in Austria and
Sweden, and 56% in Finland.
 
12
 
 HRT is used widely in
the USA. HRT use varies according to region, being
highest in the West and lowest in the North-east.
 
13
 
According to Leo 
 
et al.
 
, there is some evidence which
shows that women taking hormones from the onset
of menopause will live 4 years longer than those who
have never received HRT.
 
4
 
 Other studies have shown
that morbidity and mortality are reduced in post-
menopausal women receiving HRT.
 
11
 
It is important, when considering the outcome of
any health care intervention, to measure how such
intervention meets the patients’ needs and expecta-
tions.
 
14
 
 Patient and physician attitudes regarding
menopause and HRT may affect decisions about the
use of HRT. A number of studies have shown con-
siderable differences in attitudes among women and
physicians on issues relating to menopause and
 
sex in the HRT group did not change much after menopause, compared to
the non-HRT group. There was a significant difference between the two
groups (
 
P
 
 
 
<
 
 0.001). There were fewer changes in all aspects of sex life after
menopause for those in the HRT group compared to those in the non-HRT
group. In the month before the interview, 30.5% of the HRT group and 10.8%
of the non-HRT group had experienced complete sexual satisfaction. The
difference was significant between the two groups (
 
P
 
 
 
<
 
 0.001). On the basis
of the importance of sex during post-menopausal life, counseling on the
benefits of HRT might be recommended.
 
Key words:
 
 attitude towards sex, hormone 
replacement therapy, menopause, sex life.
 Hormone replacement and menopausal sex life
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HRT.
 
11
 
 Blumberg 
 
et al
 
. have conducted research with
the objective of determining how women aged
50 years or more felt about menopause, as well as
determining their knowledge and use of HRT, and
their attitudes towards it. They believe gynecologists
should devote more effort to public education,
because those women who had discussed HRT with
their physicians were more likely to use it.
 
7
 
There is a prevalent notion that sex does not matter
in old age. According to Scott 
 
et al.
 
, Masters and
Johnson have shown that there is a limited sexual
flush in elderly women.
 
5
 
 But the sex life is an important
aspect of health that is likely to be influenced by
medical conditions and health care interventions.
 
14
 
Ghali 
 
et al
 
. suggested that physicians should pay more
attention to their patients’ menopausal attitudes and
general health beliefs. Improved patient–physician
communication may enhance menopausal HRT coun-
seling and assist women in making decisions relating
to menopause.
 
11
 
 Higher-educated women are also
more likely to use HRT.
 
12
 
 Rosenberg 
 
et al
 
. found that
HRT use peaked at 50–54 years of age and then
declined, and that it was also positively associated
with a lower body mass index, higher level of educa-
tion, participation in vigorous exercise and previous
use of oral contraceptives. There was concern that
the study results might be confounded; therefore,
users of HRT were self-selected and the well-educated
group used HRT more than the others.
 
13
 
Making the appropriate decision regarding the use
of menopausal hormone therapy is difficult for women
and their physicians. Counseling on HRT should be
individualized, because recent reviews have clearly
demonstrated that individual patients’ medical and
family histories can alter the anticipated benefits and
risks of hormone therapy.
 
11
 
 Information about the
family history of osteoporosis, cancer and cardiovas-
cular disease should be sought.
 
4
 
 It has also been
suggested that there is insufficient information about
the potential benefits (and side effects) of HRT in the
general population.
 
12
 
 In order to be effective primary
care providers, midwives and other health-care pro-
fessionals also need adequate scientific knowledge
and the skills required to accurately assess and diag-
nose clinical problems.
 
15
 
On the basis of the above-mentioned studies, and
the fact that the sex life and sexual functioning are
important aspects of married life, the objectives of
this study were to examine the relationship between
HRT and sex life after menopause, and also to assess
the importance of sex in women receiving HRT.
 
METHOD
 
This is a comparative study that was done in the year
2000. In this study, attitudes about the importance of
sex were assessed. The sex life at the time of the
study and changes to the sex life after menopause
were examined. A valid and reliable questionnaire was
used. The questionnaire had two main parts. The first
part contained questions about personal characteris-
tics, while the second part was divided into two
sections:
1 10 questions covering libido, sexual activity, sexual
satisfaction, sexual pleasure and frequency of
orgasms, and their changes post-menopause.
Each question had four answer options.
2 Two questions covering attitudes towards sex and
their changes post-menopause. Each question had
five answer options.
The answer options related to the subject of each
question were described in terms of the degree of
change, from the least to the most. The subjects of
the questions were described as follows: (i) libido
(sexual will); (ii) sexual activity (performing the sexual
act); (iii) sexual satisfaction (the satisfaction gained by
having sex); (iv) sexual pleasure (sexual enjoyment);
(v) orgasm (the highest level of sexual enjoyment); and
(vi) attitudes towards sex (importance of sex).
The samples used in this study consisted of 154
women who were treated using HRT and 130 women
who did not receive HRT. The HRT group was chosen
from private gynecology clinics north of Tehran city
and the non-HRT group was chosen from among the
neighbors of the HRT group. For socio-economic sim-
ilarity, we tried to choose the non-HRT group mem-
bers from among the immediate neighbors (left- or
right-hand side) of the HRT group. Healthy individuals
of more than 45 years in age who were not taking any
drugs, and who did not have a history of frigidity and
had not had a hysterectomy, opharectomy or mastec-
tomy were chosen. All of them had had their last
period at least 12 months ago and had not changed
partners since their pre-menopausal days. The
descriptive and inferential statistical methods (
 
t
 
-
test, 
 
c
 
2
 
-test, Fisher exact test and Mantel Hanzel test)
were used. (The final data from the original study were
analyzed and tabulated in 55 tables, from which only
a few were chosen and summarized for this article.)
 S. Taavoni 
 
et al.
 
12
 
RESULTS
 
The average age was 53 years in the HRT group and
56 years in the non-HRT group. The highest age range
in the HRT group was 50–54 years (78%). There was
a significant difference in the average age between
the two groups (
 
P 
 
<
 
 0.001). For the two groups, 70.1%
of the women were 5–10 years post-menopause,
50% were less than 5 years post-menopause and
10% were more than 10 years post-menopause. The
average number of years post-menopause was 3.9 in
the HRT group and 5.9 in the non-HRT group. The
personal characteristics with the highest percentages
are illustrated in Table 1. For the HRT group, 91.9%
of the women used the hormone as prescribed by
their physician. All the subjects received oral HRT
except one (0.6% used estrogen cream). A combina-
tion of estrogen and progesterone was used by 89%
of the HRT group, and 10.4% used estrogen pills.
Only 8.1% of those using the estrogen and progest-
erone combination did not use the combination con-
tinuously as advised by their physician. In the HRT
group, 85.7% believed that sex was important or rel-
atively important, but this percentage in the non-HRT
group was 42.3%. While 14.3% of the HRT group
believed sex was less, or least, important, 57.1% of
the non-HRT group had the same belief. There was a
significant difference between the HRT and non-HRT
groups (
 
P 
 
<
 
 0.001). In the HRT group, 48.7% of those
aged 50–54, 41% of those aged 55–59 and 31% of
those aged 45–49 believed sex was important. There
was a correlation between age and attitudes about
the importance of sex in the HRT group (
 
P 
 
<
 
 0.001,
 
r
 
 
 
=
 
 
 
-
 
0.11). In the non-HRT group, 30.3% of those
aged 55–59, 23.5% of those aged 50–54 and 12.5%
of those aged 60–64 believed sex was important.
There was no correlation between age and attitudes
about the importance of sex in the non-HRT group.
In comparison with the pre-menopausal period, 13%
of the HRT group and 3.1% of the non-HRT group felt
that sex was now more important or much more
important, whereas there was no change in the impor-
tance of sex for 56.5% of the HRT group and 19.2%
of the non-HRT group. In the non-HRT group, 77.7%
felt that sex was less, or much less, important after
menopause, and the corresponding percentage was
29.9% in the HRT group (Table 2). For the current HRT
users, age was an important factor. Using the Mantel
Hanzel test, it was found that age was critical for both
HRT and non-HRT users in relation to their attitudes
about the importance of sex (
 
Z
 
 
 
=
 
 5.96, 
 
P
 
 
 
<
 
 0.001). The
number of years post-menopause was an important
factor for  HRT users, but not for non-HRT users
(
 
c
 
2
 
 
 
=
 
 29.67, 
 
r
 
 
 
=
 
 
 
-
 
0.3, 
 
P
 
 
 
<
 
 0.001). Using the Mantel
Hanzel test, the number of years post-menopause
was an important factor only for HRT users (
 
Z
 
 
 
=
 
 6.25,
 
P
 
 
 
<
 
 0.001).
Women receiving HRT fared better in all aspects of
their sex life, including libido, sexual activity, sexual
satisfaction, sexual pleasure and frequency of
orgasms, at the time of the study. There were signifi-
cant differences between the HRT and non-HRT
groups (
 
P
 
 
 
<
 
 0.001).
In comparison with the pre-menopausal period:
1 Libido was unchanged for 59.7% of the HRT group
and 14.6% of the non-HRT group, and was
increased only in the HRT group (16.9%) (Table 3).
 
Table 1
 
Personal characteristics with the highest percentages in the two groups and their analysis
Characteristics
Highest percentages
AnalysisHRT group Percentage (%) Non-HRT group Percentage (%)
Age (years) 50–54 50.6 55–59 58.5 Significant (
 
P
 
 
 
<
 
 0.001) (
 
t
 
 
 
=
 
 
 
-
 
6.31)
Employment housewife 70.1 housewife 92.3 Significant (
 
P
 
 
 
<
 
 0.001) (
 
c
 
2
 
 = 
 
21.9)
Education Secondary school 42.2 Primary school 60.8 Significant (
 
P
 
 
 
<
 
 0.001) (
 
c
 
2
 
 = 
 
102.36)
Number of years
post-menopause
Less than 5 70.1 5–10 46.2 Significant (
 
P
 
 < 0.000) (t = -5.6)
Number of children 3–4 51.9 More than 5 53.8 Significant (P < 0.000) (t = -4.6)
Table 2 Attitudes towards sex in the two groups in comparison
with the pre-menopausal period
Importance of sex
Group
HRT Non-HRT
No. Percentage (%) No. Percentage (%)
Increased a lot 1 0.6 0 0
Increased 20 13 4 3.1
Unchanged 87 56.5 25 19.2
Decreased 36 23.4 50 38.5
Decreased a lot 10 6.5 51 39.2
Total 154 100 130 100
Test result P < 0.001, d.f. = 2, c2 = 73.89
Hormone replacement and menopausal sex life
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2 Sexual activity was unchanged for 55.8% of the
HRT group and 15.4% of the non-HRT group, and
was increased only in the HRT group (14.9%)
(Table 4).
3 Sexual satisfaction was unchanged for 57.8% of
the HRT group and 27.7% of the non-HRT group,
and was increased for 22.7% of the HRT group and
3.1% of the non-HRT group (Table 5).
4 Sexual pleasure was unchanged for 68.5% of the
HRT group and 11.5% of the non-HRT group, and
was increased for 6.5% of the HRT group and
4.6% of the non-HRT group. For 24.7% of the HRT
group and 83.8% of the non-HRT group, sexual
pleasure was decreased compared to the pre-
menopausal period (Table 6).
5 Frequency of orgasms was unchanged for 54.5%
of the HRT group and 13.1% of the non-HRT
group, and was increased for 13.6% of the HRT
group and 3.1% of the non-HRT group (Table 7).
In comparison with the pre-menopausal period,
there were significant differences between the two
groups in relation to libido, sexual activity, sexual sat-
isfaction, sexual pleasure and frequency of orgasms
(P < 0.001).
CONCLUSION AND DISCUSSION
In this study, we found that sex was less important in
the higher age group, but HRT users had more posi-
tive attitudes about the importance of sex (P < 0.001).
The importance of sex in the HRT group did not
change much after menopause, compared to the non-
HRT group (P < 0.001). There were fewer changes in
all aspects of sex life after menopause for those in the
HRT group compared to those in the non-HRT group.
The HRT group was more satisfied with their sex life.
That is, the women had better libidos, were more
sexually active, were more satisfied, experienced
greater pleasure, and  had  more  frequent  orgasms
Table 3 Change in libido in the two groups in comparison with the
pre-menopausal period
Change in libido
Group
HRT Non-HRT
No. Percentage (%) No. Percentage (%)
Increased 26 16.9 0 0
Unchanged 92 59.7 19 14.6
Decreased 28 18.2 84 64.6
Decreased a lot 8 5.2 27 20.8
Total 154 100 130 100
Test result P < 0.001, d.f. = 2, c2 = 108.6
Table 4 Change in sexual activity in the two groups in comparison
with the pre-menopausal period
Change in sexual
activity
Group
HRT Non-HRT
No. Percentage (%) No. Percentage (%)
Increased 23 14.9 0 0
Unchanged 86 55.8 20 15.4
Decreased 32 20.8 75 57.7
Decreased a lot 13 8.4 35 26.9
Total 154 100 130 100
Test result P < 0.001, d.f. = 2, c2 = 54.004
Table 5 Change in sexual satisfaction in the two groups in com-
parison with the pre-menopausal period
Change in sexual
satisfaction
Group
HRT Non-HRT
No. Percentage (%) No. Percentage (%)
Increased 35 22.7 4 3.1
Unchanged 89 57.8 36 27.7
Decreased 15 9.7 64 49.2
Decreased a lot 15 9.7 26 20
Total 154 100 130 100
Test result P < 0.001, d.f. = 2, c2 = 74.87
Table 6 Change in sexual pleasure in the two groups in compari-
son with the pre-menopausal period
Change in sexual
pleasure
Group
HRT Non-HRT
No. Percentage (%) No. Percentage (%)
Increased 10 6.5 6 4.6
Unchanged 106 68.5 15 11.5
Decreased 28 18.2 61 46.9
Decreased a lot 10 6.5 48 36.9
Total 154 100 130 100
Test result P < 0.001, d.f. = 3, c2 = 105.29
Table 7 Change in frequency of orgasms in the two groups in
comparison with the pre-menopausal period
Change in 
frequency
of orgasms
Group
HRT Non-HRT
No. Percentage (%) No. Percentage (%)
Increased 21 13.6 4 3.1
Unchanged 84 54.5 17 13.1
Decreased 35 22.7 69 53.1
Decreased a lot 14 9.1 40 30.8
Total 154 100 130 100
Test result P < 0.001, d.f. = 2, c2 = 78.16
S. Taavoni et al.
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than  those  in the non-HRT group at the time of the
study (P < 0.001). There were significant differences
between the HRT and non-HRT groups (P < 0.001).
During the month before the interview, 30.5% of the
HRT group and 10.8% of the non-HRT group had
experienced complete sexual satisfaction, 48.7% of
the HRT group and 25.4% of the non-HRT group were
more or less sexually satisfied, 11.7% of the HRT
group and 33.1% of the non-HRT group were only a
little satisfied, and 9.1% of the HRT group and 30.8%
of the non-HRT group were not sexually satisfied.
There were significant differences between the two
groups  (P < 0.001).  Stadberg  et al.  found  that  loss
of libido occurred in 37% of menopausal women, of
whom only 21% were currently using estrogen. Non-
hormonal treatment modalities had been used by
45% of the women and were reported to be effective
against climacteric symptoms in 45% of the women
compared with 90% for the HRT users.3 In this study,
the loss of libido occurred in 23.4% of the HRT group
and 75.4% of the non-HRT group.
For this study, we tried to choose similar socio-
economic and cultural samples by selecting the non-
HRT group from the neighborhood of the HRT group.
Even though the control sample was fairly chosen by
interviewing the neighbors of the women receiving
HRT, there were significant differences in age, educa-
tion, employment, number of years post-menopause
and number of children. Therefore, in this study, there
is a limit on the accuracy of the evaluation of the effect
of HRT on sex life and attitudes towards sex. This
research was also conducted in a rich area of Tehran
with well-off and well-educated residents. We suggest
that this research be conducted in the poorer areas
as well. In this study, we asked the women in the HRT
and non-HRT groups questions about their sex life
and attitudes towards sex post-menopause and pre-
menopause, and also about the changes in these
areas. For a more precise study on pre-menopausal
sex life and attitudes towards sex compared with
post-menopausal sex life and attitudes towards sex
in both HRT and non-HRT groups, a longitudinal
study should be conducted. With reference to the pre-
menopausal period, the highest percentage of women
who did not experience any change in their sex life or
attitudes towards sex came from the HRT group. This
means that the use of hormones prevented complica-
tions arising from a decrease in hormone production
after menopause. Even though there is a limit on the
accuracy of our findings, on the basis of the impor-
tance of sex during post-menopausal life, counseling
on the benefits of HRT might be recommended. We
suggest using the following procedure for the man-
agement of menopause: (i) recognize the impending
hormonal dysfunction early in women who are pre-
sented for menopausal evaluation; (ii) obtain a
detailed personal history and conduct a thorough
physical examination of the patient; (iii) provide appro-
priate advice and education, and initiate HRT; (iv)
monitor  the  patient  regularly  to  assess  the  efficacy
of treatment and detect any complications; and (v)
adjust the treatment accordingly.4
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